Skip to main content
. 2017 Aug 2;2017(8):CD001324. doi: 10.1002/14651858.CD001324.pub5
Methods Women 'randomly allocated' to 2 groups. Method of randomisation not reported
Participants 200 women attending an MCH clinic in Guangzhou, China. Women had regular menstrual periods and attended the clinic within 72 h of a single act of unprotected intercourse
Interventions Mife 50 mg vs Mife 25 mg orally single dose
Outcomes Observed number of pregnancies, side effects, changes in menstrual pattern
Notes
  1. No mention of post‐randomisation exclusion and loss to follow‐up

  2. Observed pregnancy/expected pregnancy/total number of women: Mife 50 mg 0/12/100, Mife 25 mg 1/13/100

  3. No loss to follow‐up

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Mentioned randomisation but description not adequate
Allocation concealment (selection bias) Unclear risk Method of allocation concealment not mentioned
Blinding (performance bias and detection bias) All outcomes Unclear risk Not mentioned
Incomplete outcome data (attrition bias) All outcomes Unclear risk No mention of post‐randomisation exclusion and loss to follow‐up
Selective reporting (reporting bias) Low risk Planned outcome of pregnancy rate was reported
Other bias Low risk None detected